Although loss of E-cadherin is a hallmark of EMT, in BC this alteration typically occurs in lobular cancer, both in situ and invasive, a tumor type that does not have other typical characteristics of EMT, indicating that E-cadherin loss is necessary but not sufficient to develop a complete EMT program. Here, CDH1 is linked to breast cancer.